Weinberg V - Search Results

1

Longitudinal study of smoking progression in Chinese and Vietnamese American adolescents.

Kaplan CP, Nguyen TT, Weinberg V. Kaplan CP, et al. Among authors: weinberg v. Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):335-41. Asian Pac J Cancer Prev. 2008. PMID: 18712987

2

Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.

Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, Lee NY, Yom SS, Phillips TL, Quivey JM. Huang K, et al. Among authors: weinberg v. Cancer. 2008 Aug 1;113(3):497-507. doi: 10.1002/cncr.23578. Cancer. 2008. PMID: 18521908

3

Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.

Fong L, Kwek SS, O'Brien S, Kavanagh B, McNeel DG, Weinberg V, Lin AM, Rosenberg J, Ryan CJ, Rini BI, Small EJ. Fong L, et al. Among authors: weinberg v. Cancer Res. 2009 Jan 15;69(2):609-15. doi: 10.1158/0008-5472.CAN-08-3529. Cancer Res. 2009. PMID: 19147575 Clinical Trial.

4

Palliative and oncologic co-management: symptom management for outpatients with cancer.

Bischoff K, Weinberg V, Rabow MW. Bischoff K, et al. Among authors: weinberg v. Support Care Cancer. 2013 Nov;21(11):3031-7. doi: 10.1007/s00520-013-1838-z. Epub 2013 Jun 21. Support Care Cancer. 2013. PMID: 23794100

5

Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?

Roach M 3rd, Weinberg V, Sandler H, Thompson I. Roach M 3rd, et al. Among authors: weinberg v. Cancer. 2007 Jan 15;109(2):213-20. doi: 10.1002/cncr.22403. Cancer. 2007. PMID: 17167758

6

Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.

Friedlander TW, Ngo VT, Dong H, Premasekharan G, Weinberg V, Doty S, Zhao Q, Gilbert EG, Ryan CJ, Chen WT, Paris PL. Friedlander TW, et al. Among authors: weinberg v. Int J Cancer. 2014 May 15;134(10):2284-93. doi: 10.1002/ijc.28561. Epub 2014 Jan 2. Int J Cancer. 2014. PMID: 24166007

7

A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma.

Rini BI, Weinberg V, Small EJ. Rini BI, et al. Among authors: weinberg v. Cancer. 2005 Feb 1;103(3):553-8. doi: 10.1002/cncr.20795. Cancer. 2005. PMID: 15612026 Clinical Trial.

8

Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma.

Rini BI, Weinberg V, Shaw V, Scott J, Bok R, Park JW, Small EJ. Rini BI, et al. Among authors: weinberg v. Cancer. 2004 Jul 1;101(1):90-5. doi: 10.1002/cncr.20313. Cancer. 2004. PMID: 15221993 Clinical Trial.

9

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium.

Harzstark AL, Rosenberg JE, Weinberg VK, Sharib J, Ryan CJ, Smith DC, Pagliaro LC, Beer TM, Liu G, Small EJ. Harzstark AL, et al. Cancer. 2011 Jun 1;117(11):2419-25. doi: 10.1002/cncr.25810. Epub 2010 Dec 29. Cancer. 2011. PMID: 24048789 Clinical Trial.

10

A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma.

Harzstark AL, Small EJ, Weinberg VK, Sun J, Ryan CJ, Lin AM, Fong L, Brocks DR, Rosenberg JE. Harzstark AL, et al. Cancer. 2011 Sep 15;117(18):4194-200. doi: 10.1002/cncr.25931. Epub 2011 Mar 8. Cancer. 2011. PMID: 21387258 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results